Skip to main content

News & Media

Take a closer look at what we’re doing across Teva in Canada and worldwide

Teva Canada Limited, headquartered in Toronto, and Teva Canada Innovation, headquartered in Montréal, are part of Teva Pharmaceutical Industries Ltd., the world’s largest generic drug maker. We’re proud to have been part of Canadian healthcare for more than 50 years, to market more than 400 medications across the country and to employ more than 1,000 Canadians.

If you’re looking for information about our company, please contact Public Affairs at Teva Canada Limited at Public.Affairs@tevacanada.com.

COVID-19: We'll get through this together

As the COVID-19 situation evolves globally, we are striving to provide an uninterrupted supply of medicines to the 200 million patients that we serve around the world. The global emergency surrounding COVID-19 is disrupting the family, work and social lives of many people around the world. At Teva, we’re working hard to keep the flow of medicines going to patients and healthcare systems. Thousands of colleagues have adapted the way they operate in order to continue performing essential work on our production lines, warehouses and distribution networks. See how Teva is working to keep medicines moving.

Watch video COVID-19: We'll get through this together

Latest news

Read the latest Teva news

Teva Canada announces availability of Aermony RespiClick™, an innovative new device for the treatme...

Teva Canada announces availability of Aermony RespiClick™, an innovative new device for the treatment of bronchial asthma

Teva Canada announces product availability of AJOVY™

Teva Canada announces product availability of AJOVY™

CGPA releases blueprint for a sustainable supply of prescription medicines for Canadians

CGPA releases blueprint for a sustainable supply of prescription medicines for Canadians

Teva Canada secures Salbutamol Inhalers from its global supply chain to mitigate shortage in Canadia...

Teva Canada secures Salbutamol Inhalers from its global supply chain to mitigate shortage in Canadian market

Availability of UK-Labelled Product – Salbutamol Metered Dose Inhaler (MDI)

Availability of UK-Labelled Product – Salbutamol Metered Dose Inhaler (MDI)

Importation of Teva UK-labelled Salamol CFC-Free (Salbutamol Sulfate) Inhaler due to shortage

Importation of Teva UK-labelled Salamol CFC-Free (Salbutamol Sulfate) Inhaler due to shortage

Teva Canada announces the launch of AJOVY™

Teva Canada announces the launch of AJOVY™

COVID-19 is increasing the number of Canadians requiring caregiver information and support

COVID-19 is increasing the number of Canadians requiring caregiver information and support

Featured stories